Accelerating Access to Critical Therapies for ALS Act

Pub. L. 117–79

2 sections of the Code credited to this law, found between Public Law 117-78, except 58 and Public Law 117-79, except 58.

• 21 U.S.C. § 360ee–1 — FDA rare neurodegenerative disease grant program
• 42 U.S.C. § 280g–7b — HHS public-private partnership for rare neurodegenerative diseases